Titan Biotech Limited (TITANBIO.BO)
INR 781.0
(1.07%)
INR 781.0
(1.07%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 315.89 Million INR | 12.85% |
| 2022 | 274.25 Million INR | -6.22% |
| 2021 | 292.44 Million INR | -33.3% |
| 2020 | 438.42 Million INR | 275.28% |
| 2019 | 116.82 Million INR | 61.97% |
| 2018 | 72.12 Million INR | 19.36% |
| 2017 | 60.42 Million INR | 32.39% |
| 2016 | 45.64 Million INR | 47.69% |
| 2015 | 30.9 Million INR | -6.87% |
| 2014 | 33.18 Million INR | 28.42% |
| 2013 | 25.84 Million INR | 4.43% |
| 2012 | 24.74 Million INR | 26.69% |
| 2011 | 19.53 Million INR | 20.58% |
| 2010 | 16.19 Million INR | 25.28% |
| 2009 | 12.93 Million INR | 10.93% |
| 2008 | 11.65 Million INR | 6.69% |
| 2007 | 10.92 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 72.02 Million INR | 15.45% |
| 2023 Q2 | 78.53 Million INR | 10.75% |
| 2023 Q1 | 70.91 Million INR | 15.85% |
| 2023 Q4 | 62.38 Million INR | -38.86% |
| 2023 FY | 309.5 Million INR | 12.85% |
| 2023 Q3 | 102.04 Million INR | 29.93% |
| 2022 Q3 | 37.7 Million INR | -61.7% |
| 2022 Q4 | 61.21 Million INR | 62.36% |
| 2022 FY | 274.25 Million INR | -6.22% |
| 2022 Q1 | 74.61 Million INR | 11.11% |
| 2022 Q2 | 98.43 Million INR | 31.92% |
| 2021 Q1 | 138.23 Million INR | 114.73% |
| 2021 FY | 292.44 Million INR | -33.3% |
| 2021 Q2 | 98.52 Million INR | -28.73% |
| 2021 Q3 | 80.67 Million INR | -18.12% |
| 2021 Q4 | 67.15 Million INR | -16.75% |
| 2020 FY | 438.42 Million INR | 275.28% |
| 2020 Q2 | 110.7 Million INR | -38.34% |
| 2020 Q3 | 93.08 Million INR | -15.92% |
| 2020 Q4 | 64.37 Million INR | -30.84% |
| 2020 Q1 | 179.55 Million INR | 582.21% |
| 2019 FY | 116.82 Million INR | 61.97% |
| 2019 Q1 | 41.99 Million INR | 138.82% |
| 2019 Q2 | 22.08 Million INR | -47.4% |
| 2019 Q3 | 28.21 Million INR | 27.73% |
| 2019 Q4 | 26.31 Million INR | -6.71% |
| 2018 Q3 | 19.79 Million INR | -16.04% |
| 2018 Q4 | 17.58 Million INR | -11.16% |
| 2018 Q2 | 23.57 Million INR | 29.59% |
| 2018 Q1 | 18.19 Million INR | -10.37% |
| 2018 FY | 72.12 Million INR | 19.36% |
| 2017 Q3 | 16.07 Million INR | -7.48% |
| 2017 FY | 60.42 Million INR | 32.39% |
| 2017 Q4 | 20.29 Million INR | 26.28% |
| 2017 Q2 | 17.37 Million INR | 29.19% |
| 2017 Q1 | 13.44 Million INR | -12.49% |
| 2016 Q4 | 15.36 Million INR | 22.88% |
| 2016 FY | 45.64 Million INR | 47.69% |
| 2016 Q1 | 9.31 Million INR | 32.32% |
| 2016 Q3 | 12.5 Million INR | 13.05% |
| 2016 Q2 | 11.06 Million INR | 18.79% |
| 2015 FY | 30.9 Million INR | -6.87% |
| 2015 Q4 | 7.03 Million INR | -15.87% |
| 2015 Q3 | 8.36 Million INR | -10.17% |
| 2015 Q2 | 9.31 Million INR | 20.78% |
| 2015 Q1 | 7.7 Million INR | -7.17% |
| 2014 Q1 | 7.74 Million INR | 1.43% |
| 2014 FY | 33.18 Million INR | 28.42% |
| 2014 Q3 | 7.66 Million INR | -18.1% |
| 2014 Q2 | 9.35 Million INR | 20.85% |
| 2014 Q4 | 8.3 Million INR | 8.34% |
| 2013 Q2 | 6.39 Million INR | 16.15% |
| 2013 Q4 | 7.63 Million INR | 21.02% |
| 2013 Q1 | 5.5 Million INR | -23.2% |
| 2013 Q3 | 6.3 Million INR | -1.31% |
| 2013 FY | 25.84 Million INR | 4.43% |
| 2012 Q4 | 7.16 Million INR | 41.24% |
| 2012 Q1 | 5.38 Million INR | 44.12% |
| 2012 Q2 | 7.12 Million INR | 32.43% |
| 2012 Q3 | 5.07 Million INR | -28.79% |
| 2012 FY | 24.74 Million INR | 26.69% |
| 2011 Q4 | 3.73 Million INR | -28.27% |
| 2011 Q3 | 5.2 Million INR | 0.0% |
| 2011 FY | 19.53 Million INR | 20.58% |
| 2010 Q4 | 4.15 Million INR | 0.0% |
| 2010 FY | 16.19 Million INR | 25.28% |
| 2009 FY | 12.93 Million INR | 10.93% |
| 2008 FY | 11.65 Million INR | 6.69% |
| 2008 Q4 | 1.54 Million INR | 0.0% |
| 2007 FY | 10.92 Million INR | 0.0% |
| 2007 Q4 | 2.43 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 9.28 Million INR | -3302.973% |
| Biocon Limited | 50.83 Billion INR | 99.379% |
| Blue Jet Healthcare Limited | 3.37 Billion INR | 90.632% |
| Concord Biotech Limited | 6.26 Billion INR | 94.955% |
| Dishman Carbogen Amcis Limited | -13.9 Million INR | 2372.647% |
| FERMENTA BIOTECH LIMITED | 1.06 Billion INR | 70.42% |
| GENOMIC VALLEY BIOTECH LIMITED | 1.27 Million INR | -24661.748% |
| Lyka Labs Limited | 29.13 Million INR | -984.442% |
| Panacea Biotec Limited | -309.7 Million INR | 202.001% |
| SAMSRITA LABS LIMITED | -1.49 Million INR | 21196.716% |
| Servoteach Industries Limited | -785.00 INR | 40241883.439% |
| SMS Lifesciences India Limited | 359.47 Million INR | 12.122% |
| Supriya Lifescience Limited | 1.57 Billion INR | 79.9% |
| Syngene International Limited | 14.02 Billion INR | 97.748% |
| TAKE Solutions Limited | -213.49 Million INR | 247.969% |
| Transgene Biotek Limited | -7.08 Million INR | 4556.172% |
| Vanta Bioscience Limited | -31.83 Million INR | 1092.204% |